AKT1 and hepatocellular carcinoma: The protein kinase B/mechanistic target of rapamycin pathway, a critical pathway in tumor cell growth and metabolic regulation, upon aberrant activation, can enhance cell cycle progression and accelerate HCC progression (Bang et al., 2023).